Evidence map›Paper›PMID 30387920›Full record

ReviewBasic & clinical pharmacology & toxicology2019

Timescales of developmental toxicity impacting on research and needs for intervention.

Philippe Grandjean, Latifa Abdennebi-Najar, Robert Barouki, Carl F Cranor, Ruth A Etzel, David Gee, Jerrold J Heindel, Karin S Hougaard, Patricia Hunt, Tim S Nawrot and 5 more

Abstract readReview
In one paragraph

Review in Basic & clinical pharmacology & toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Addressing systemic problems with exposure assessments to protect the public's health.Environmental health : a global access science source · 2023
    Review
  7. Pollution and health: a progress update.The Lancet. Planetary health · 2022
    Review
  8. Microplastics, environment and child health.Italian journal of pediatrics · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Down syndrome.Nature reviews. Disease primers · 2020
    Review
  13. Article
  14. Development priority.Basic & clinical pharmacology & toxicology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Philippe GrandjeanDepartment of Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Latifa Abdennebi-NajarQuality and Health Department, IDELE Institute, Paris, France.
Robert BaroukiINSERM UMR-S 1124, Université Paris Descartes, Paris, France.
Carl F CranorDepartment of Philosophy, University of California, Riverside, California.
Ruth A EtzelMilken Institute, School of Public Health, The George Washington University, Washington, District of Columbia.
David GeeInstitute of Environment, Health and Societies, Brunel University, London, UK.
Jerrold J HeindelProgram in Endocrine Disruption Strategies, Commonweal, Bolinas, California.
Karin S HougaardNational Research Centre for the Working Environment, Copenhagen, Denmark.
Patricia HuntSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington.
Tim S NawrotCentre for Environmental Sciences, Hasselt University, Hasselt, Belgium.
Gail S PrinsChicago Center for Health and Environment (CACHET), University of Illinois at Chicago, Chicago, Illinois.
Beate RitzDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California.
Morando SoffrittiRamazzini Institute, Bologna, Italy.
Jordi SunyerISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Catalonia, Spain.
Pal WeiheDepartment of Public Health and Occupational Medicine, Tórshavn, Faroe Islands.

Funding

Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWALP42ES027706 · NIEHS · UNIVERSITY OF RHODE ISLAND · PI Elsie Mareca Sunderland · 2017 to 2026
$18.9M
Inflammation and metabolic abnormalities in pollutant-exposed childrenR01ES026596 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI GRANDJEAN, PHILIPPE ADAM · 2017 to 2018
$321k
Prenatal Programming and Toxicity (PPTOX) V1R13ES029385 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI GRANDJEAN, PHILIPPE ADAM · 2018 to 2018
$8k
NIEHS NIH HHS P42 ES027706NIEHS NIH HHS R01 ES026596NIEHS NIH HHS R13 ES029385NIEHS NIH HHS R13ES029385STEEP Superfund Center P42ES027706
6 · The paper itself

Abstract

Much progress has happened in understanding developmental vulnerability to preventable environmental hazards. Along with the improved insight, the perspective has widened, and developmental toxicity now involves latent effects that can result in delayed adverse effects in adults or at old age and additional effects that can be transgenerationally transferred to future generations. Although epidemiology and toxicology to an increasing degree are exploring the adverse effects from developmental exposures in human beings, the improved documentation has resulted in little progress in protection, and few environmental chemicals are currently regulated to protect against developmental toxicity, whether it be neurotoxicity, endocrine disruption or other adverse outcome. The desire to obtain a high degree of certainty and verification of the evidence used for decision-making must be weighed against the costs and necessary duration of research, as well as the long-term costs to human health because of delayed protection of vulnerable early-life stages of human development and, possibly, future generations. Although two-generation toxicology tests may be useful for initial test purposes, other rapidly emerging tools need to be seriously considered from computational chemistry and metabolomics to CLARITY-BPA-type designs, big data and population record linkage approaches that will allow efficient generation of new insight; epigenetic mechanisms may necessitate a set of additional regulatory tests to reveal such effects. As reflected by the Prenatal Programming and Toxicity (PPTOX) VI conference, the current scientific understanding and the timescales involved require an intensified approach to protect against preventable adverse health effects that can harm the next generation and generations to come. While further research is needed, the main emphasis should be on research translation and timely public health intervention to avoid serious, irreversible and perhaps transgenerational harm.

Indexed as

AnimalsBig DataComputational ChemistryCongresses as TopicDisease Models, AnimalEcotoxicologyEndocrine DisruptorsEnvironmental ExposureEnvironmental MedicineEpigenesis, GeneticEpigenomicsFemaleFetal DevelopmentHumansMetabolomicsPregnancyEndocrine Disruptors

Identifiers

PMID30387920
PMCPMC6497561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.